These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15882757)

  • 1. Measurement of the mechanical characteristics of benign prostatic tissue: a novel method for assessing benign prostatic disease.
    Phipps S; Yang TH; Habib FK; Reuben RL; McNeill SA
    Urology; 2005 May; 65(5):1024-8. PubMed ID: 15882757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of tissue mechanical characteristics to distinguish between benign and malignant prostatic disease.
    Phipps S; Yang TH; Habib FK; Reuben RL; McNeill SA
    Urology; 2005 Aug; 66(2):447-50. PubMed ID: 16098374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative morphometric analysis of individual resected prostatic tissue specimens, using immunohistochemical staining and colour-image analysis.
    Phipps S; Habib FK; McNeill A
    BJU Int; 2004 Oct; 94(6):919-21. PubMed ID: 15476536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro dynamic micro-probing and the mechanical properties of human prostate tissues.
    Yang TH; Leung SK; Phipps S; Reuben RL; McNeill SA; Habib FK; Schnieder A; Stevens R
    Technol Health Care; 2006; 14(4-5):281-96. PubMed ID: 17065751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between morphometric differences and norepinephrine content in benign prostatic hyperplasia.
    Ishigooka M; Hashimoto T; Hayami S; Suzuki Y; Sasagawa I; Nakada T
    Prostate; 1996 Jun; 28(6):385-91. PubMed ID: 8650076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative and total volume of histological components in benign prostatic hyperplasia: relationships between histological components and clinical findings.
    Ishigooka M; Hayami S; Hashimoto T; Suzuki Y; Katoh T; Nakada T
    Prostate; 1996 Aug; 29(2):77-82. PubMed ID: 8700803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative proportions of tissue components in the prostate: are they related to the development of symptomatic BPH in Korean men?
    Byun SS; Jeong H; Jo MK; Lee E
    Urology; 2005 Sep; 66(3):593-6. PubMed ID: 16140084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relation between the prostatic tissue components and natural history, estrogen receptor].
    Matsuda T; Abe H; Suda K
    Rinsho Byori; 2003 Dec; 51(12):1180-3. PubMed ID: 14743740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expressions of endothelin-1 in benign prostatic hyperplasia and prostate cancer and their significance].
    Zhou WQ; Sun YH; Yin HL; Zhang ZY; Ge JP; Cheng W; Ma HQ; Wei W; Zhou SG; Ma HH; Gao JP
    Zhonghua Nan Ke Xue; 2007 Aug; 13(8):685-9. PubMed ID: 17918704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Finasteride effects on hypoxia and angiogenetic markers in benign prostatic hyperplasia.
    Lekas AG; Lazaris AC; Chrisofos M; Papatsoris AG; Lappas D; Patsouris E; Deliveliotis C
    Urology; 2006 Aug; 68(2):436-41. PubMed ID: 16904480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for prostatic inflammation extent and infection in benign prostatic hyperplasia.
    Yi FX; Wei Q; Li H; Li X; Shi M; Dong Q; Yang YR
    Asian J Androl; 2006 Sep; 8(5):621-7. PubMed ID: 16751994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An autopsy specimen study of benign hyperplastic nodules in the peripheral zone of the prostate].
    Liu X; Tang J; Yang JC; Zhang Y; Shi HY
    Zhonghua Nan Ke Xue; 2008 Apr; 14(4):307-10. PubMed ID: 18481420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transurethral microwave thermotherapy of the prostate--evaluation with MRI and analysis of parameters relevant to outcome.
    Vesely S; Müller M; Knutson T; Peeker R; Hellström M; Dahlstrand C
    Scand J Urol Nephrol; 2008; 42(1):53-8. PubMed ID: 18210336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in cancerous and benign prostatic tissue.
    Hudolin T; Juretic A; Spagnoli GC; Pasini J; Bandic D; Heberer M; Kosicek M; Cacic M
    Prostate; 2006 Jan; 66(1):13-8. PubMed ID: 16114059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New histopathological experimental model for benign prostatic hyperplasia: stromal hyperplasia in rats.
    Mori F; Oda N; Sakuragi M; Sakakibara F; Kiniwa M; Miyoshi K
    J Urol; 2009 Feb; 181(2):890-8. PubMed ID: 19095262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostatic stromal cells derived from benign prostatic hyperplasia specimens possess stem cell like property.
    Lin VK; Wang SY; Vazquez DV; C Xu C; Zhang S; Tang L
    Prostate; 2007 Sep; 67(12):1265-76. PubMed ID: 17597114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of NKX3.1 in benign prostatic hyperplasia.
    Irer B; Toylu A; Aslan G; Celebi I; Yorukoglu K; Atabey N
    Urology; 2009 May; 73(5):1140-4. PubMed ID: 18597829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of AIbZIP and Cdc47 as markers for human prostatic diseases.
    Levesque MH; El-Alfy M; Berger L; Labrie F; Labrie C
    Urology; 2007 Jan; 69(1):196-201. PubMed ID: 17270658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign prostatic obstruction and parkinson's disease--should transurethral resection of the prostate be avoided?
    Roth B; Studer UE; Fowler CJ; Kessler TM
    J Urol; 2009 May; 181(5):2209-13. PubMed ID: 19296974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.